Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
Year: 2019
Type: editorial
Abstract: Chronic hepatitis C virus (HCV) infection is a major cause of liver disease and hepatocellular carcinoma (HCC)-the second leading, and rising, cause of death due to cancer world-wide [...].
Source: Viruses
DOI: 10.3390/v11050441
Authors: Thomas F. Baumert, Yujin Hoshida
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,824
Funders: U.S. Department of Defense, Styrelsen för Internationellt Utvecklingssamarbete, European Commission, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Agence Nationale de Recherches sur le Sida et les Hépatites Virales, Université de Strasbourg, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Molecular Prognostic Indicators in Liver Cirrhosis and Cancer, G3904479372, G3936374592, G4119534169, G434337789, G4453869025, Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities., G5850682332, G6886055412, G7240651115, G7376787254, GENE REGULATORY NETWORKS AS TARGETS AND BIOMARKERS FOR LIVER CANCER CHEMOPREVENTION AFTER CLEARANCE OF ONCOGENIC HEPATITIS C VIRUS, Glycopathology of HCC: identification of the source cells of serum fucosylation, Functional genomics of viral hepatitis and liver disease, G923630067
OpenAlex ID: W2945504124